About the Lab
The Endocrine, Metabolic and Reproductive Advancements (EMBRACE) Women’s Health Research Lab at the University of Calgary in Calgary, Canada aims to enhance reproductive and cardiometabolic health across the life course in individuals affected by reproductive endocrine disorders, such as polyendocrine metabolic ovarian syndrome (PMOS) and gestational diabetes.
Our Research
Our team is at the forefront of women’s health research. Through innovative studies, we aim to uncover new diagnostic tools, treatments, and preventative measures.
Throughout the research process, we work closely with people with lived experience and experts from related clinical and research fields.
By participating in or donating to our research program, you are helping to shape the future of women’s health care.
Participate in Our Research
Are you interested in participating our studies? Let’s start a conversation.
Collaborators
For researchers, institutions, journalists & publications that wish to collaborate with our team on future & ongoing studies.
Lab News
June 9, 2026
On June 9th, members of our team attended the StrongHER Together Women’s Health and Wellness event....
May 12-15, 2026
Graduate student Sherry Brudnyi attended the Organization for the Study of Sex Differences (OSSD) conference in...
May 29, 2026
Dr. Jamie Benham was a keynote speaker at the 2026 Clara Christie Research Day on May...
Latest Publications
Development of a case definition for polycystic ovary syndrome using administrative health data: a validation study
Salem JN, Vettese R, Yamamoto JM, Koshy S, Harrison T, Stephenson N, et al. BMJ Open. 2025;15(11):e097971. doi:10.1136/bmjopen-2024-097971.
Closed-Loop Insulin Delivery in Type 1 Diabetes in Pregnancy: The CIRCUIT Randomized Clinical Trial
Donovan LE, Lemieux P, Dunlop AD, Yamamoto JM, Murphy HR, Simmons D, et al.; CIRCUIT Collaborative Group. JAMA. 2025;[Epub ahead of print]:e2519578. doi:10.1001/jama.2025.19578.
Validity of administrative health data case definitions for identifying polycystic ovary syndrome: a systematic review and meta-analysis.
Hu S, Lalonde-Bester S, Salem J, Koshy S, Vine D, Harrison TG, Yamamoto JM, Benham JL. Hum Reprod. 2025. Online ahead of print. PMID: 40381996
Virtual vs. in-person care in gestational diabetes management: a retrospective cohort analysis
Dolatabadi S, Yamamoto JM, Brennand EA, Donovan LE, Benham JL.
Uptake and factors associated with COVID-19 vaccination among 3,779,733 adults living with and without diabetes: a population cohort study in a universal healthcare setting
Butalia S, Sigal RJ, Shah BR, Benham JL, Wicklow B, Yu CH, Dasgupta K, Chu LM, Amed S, Constantinescu C, Kaul P. Can J Diabetes. 2025.
Gestational diabetes laboratory testing in Alberta before and during the COVID-19 pandemic
Benham JL, Stephenson N, Metcalfe A, Donovan LE, Feig DS, Pylypjuk C, Ruth C, Berger H, Sigurdson SM, Shah BR, Yamamoto JM. Can J Diabetes. 2025.